Literature DB >> 8248038

In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells.

O Genbacev1, K D Jensen, S S Powlin, R K Miller.   

Abstract

Tissue explants of anchoring villi from the first trimester placentae cultured on extracellular matrix (Matrigel) give rise to EVT cells in vitro. This study was designed to address two issues important for further application of the described in vitro model: first, were the observed EVT cells derived by cell proliferation in vitro and second, what is the degree of homology between the in vivo and the in vitro differentiated EVT cells. The cultures (tissue and matrix) were prepared for light and electron microscopic (EM) examinations. Semi-thin sections from Spurr epoxy resin-embedded tissue were used to 'pop-off' the selected area for EM examination. Cell proliferation in vitro was assessed immunohistochemically using proliferative cell nuclear antigen (PCNA) antibodies. Since positive hPL immunostaining has been consistently demonstrated in the invasive subpopulation of EVT cells from placental bed in situ, hPL staining was used as a marker of EVT cell differentiation in vitro. It has been demonstrated that PCNA antibodies immunostained nuclei of cytotrophoblast cells from cell column at the base of the anchoring villi, indicating that these cells expressed proliferative activity in vitro. Cytotrophoblast proliferation resulted in the formation of the flattened zone of cell outgrowths at the tip of anchoring villi. Cells from the distal layer of the cell column detached gradually and migrated into the surrounding matrix. These cells appeared as individual, round-shaped EVT cells with smooth surface cell membrane. Their cytoplasm was rich in glycogen and contained large lipid droplets and flattened cisternae of the RER. Positive PCNA immunostaining, along with the presence of mitotic figures, indicated that EVT cells in vitro retained the ability for cell proliferation. As a result of cell proliferation and migration, the number of EVT cells increased during the culture period of 4 days. EVT cell glycogen content and lipid stores decreased progressively as they migrated into the matrix. Individual EVT cells, as well as EVT cell clusters, became surrounded by the clear zone of digested matrix. Some cells started to express strong positive staining with hPL antibodies as soon as they had migrated outside the villous explant. By day 4 of culture, a small percentage of EVT cells (about 5-10%) ceased to migrate, firmly attached to the substratum and appeared as irregular shaped cells with filopodia-like projections. Their cytoplasm contained dilated cisternae of RER, a small number of glycogen granules and bundles of actin-like filaments located in the cytoplasm inside the plasma membrane.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8248038     DOI: 10.1016/s0143-4004(05)80466-7

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  17 in total

1.  Establishment of human trophoblast progenitor cell lines from the chorion.

Authors:  Olga Genbacev; Matthew Donne; Mirhan Kapidzic; Matthew Gormley; Julie Lamb; Jacqueline Gilmore; Nicholas Larocque; Gabriel Goldfien; Tamara Zdravkovic; Michael T McMaster; Susan J Fisher
Journal:  Stem Cells       Date:  2011-09       Impact factor: 6.277

2.  Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro.

Authors:  D Ilić; O Genbacev; F Jin; E Caceres; E A Almeida; V Bellingard-Dubouchaud; E M Schaefer; C H Damsky; S J Fisher
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway.

Authors:  Gali Epstein Shochet; Shelly Tartakover-Matalon; Liat Drucker; Metsada Pasmanik-Chor; Meir Pomeranz; Ami Fishman; Michael Lishner
Journal:  Clin Exp Metastasis       Date:  2014-10-15       Impact factor: 5.150

4.  Lipopolysaccharide induces cytokine production and decreases extravillous trophoblast invasion through a mitogen-activated protein kinase-mediated pathway: possible mechanisms of first trimester placental dysfunction.

Authors:  Lauren Anton; Amy G Brown; Samuel Parry; Michal A Elovitz
Journal:  Hum Reprod       Date:  2011-11-03       Impact factor: 6.918

5.  The orphan nuclear receptor NUR77 promotes trophoblast invasion at early pregnancy through paracrine placental growth factor.

Authors:  Xiao-Cui Li; Xiang-Jie Yin; Wei Hong; Jie Liu; Feng Jin; Bei-Ying Wang; Yu-Mei Wang; Fu-Ju Tian
Journal:  J Mol Med (Berl)       Date:  2019-07-16       Impact factor: 4.599

Review 6.  Human trophoblast progenitors: where do they reside?

Authors:  Olga Genbacev; Julie D Lamb; Akraporn Prakobphol; Matt Donne; Michael T McMaster; Susan J Fisher
Journal:  Semin Reprod Med       Date:  2013-01-17       Impact factor: 1.303

Review 7.  Critical growth factors and signalling pathways controlling human trophoblast invasion.

Authors:  Martin Knöfler
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

8.  EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR).

Authors:  S Brouillet; P Murthi; P Hoffmann; A Salomon; F Sergent; P De Mazancourt; M Dakouane-Giudicelli; M N Dieudonné; P Rozenberg; D Vaiman; S Barbaux; M Benharouga; J-J Feige; N Alfaidy
Journal:  Cell Mol Life Sci       Date:  2012-09-02       Impact factor: 9.261

Review 9.  Molecular and immunological developments in placentas.

Authors:  Akitoshi Nakashima; Tomoko Shima; Aiko Aoki; Mihoko Kawaguchi; Ippei Yasuda; Sayaka Tsuda; Satoshi Yoneda; Akemi Yamaki-Ushijima; Shi-Bin Cheng; Surendra Sharma; Shigeru Saito
Journal:  Hum Immunol       Date:  2021-02-11       Impact factor: 2.850

10.  Evidence from the very beginning: endoglandular trophoblasts penetrate and replace uterine glands in situ and in vitro.

Authors:  G Moser; G Weiss; M Gauster; M Sundl; B Huppertz
Journal:  Hum Reprod       Date:  2015-10-22       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.